Post AIDS 2022 Webinar: Expert Panel Discussion of 2022 AIDS ViiV-Sponsored Data
POST AIDS 2022 Webinar
Expert Panel Discussion of 2022 AIDS ViiV-Sponsored DataExpert discussions recorded during AIDS 2022 in Montreal, Canada
Utilizing and Applying Findings from Observational Studies in AIDS Research
Shelly Dhir, PharmD Sr. Director, Portfolio Medical LeadDr. Rick Elion, MD Director of Clinical Research, Washington Health Institute and Clinical Professor of Medicine George Washington University School of Medicine
Using Fewer HIV Treatments When Treating HIV Long Term
Andrew Zolopa, MD VP, Head, North American Medical Affairs ViiV HealthcareDr. Babafemi Taiwo, MD, MBBS Gene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases Northwestern University
Discussing CABENUVA Data at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical AffairsDr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers
Discussing the BRIGHTE Study at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical AffairsDr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch